The management of cardiogenic shock is an ongoing challenge. Despite all efforts and
tremendous use of resources, mortality remains high. Whilst reversing the underlying cause …

Acute heart failure (HF) presents a significant mortality burden, necessitating continuous
therapeutic advancements. Temporary mechanical circulatory support (MCS) is crucial in …

Background Percutaneous active mechanical circulatory support (MCS) devices are being
increasingly used in the treatment of acute myocardial infarction-related cardiogenic shock …

Mechanical circulatory support (MCS) devices are considered last-resort treatment options
for patients in advanced stages of cardiogenic shock (CS) despite a dearth of high-quality …

Purpose Despite systemic thrombolysis, a few patients with high-risk pulmonary embolism
(PE) remain hemodynamically unstable. Venoarterial extracorporeal membrane …

Abstract Background and Aims Cardiogenic shock (CS) remains the primary cause of in-
hospital death after acute coronary syndromes (ACS), with its plateauing mortality rates …

Methods The Critical Care Cardiology Trials Network (CCCTN) is an investigator-initiated
research network of CICUs coordinated by the TIMI Study Group. The CCCTN Registry …

BACKGROUND: In DanGer Shock (the Danish–German Cardiogenic Shock trial), use of a
microaxial flow pump (mAFP) in patients with ST-segment–elevation myocardial infarction …

The paradigm shift in the management of cardiogenic shock: moving from pure mechanical
left ventricular unloading to neurohumoral and anti-inflammatory blockade with or without …

Abstract Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to
reducing the mortality of patients with ST-segment elevation myocardial infarction (STEMI) …